- Report
- June 2018
- 70 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- August 2023
- 112 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- May 2023
- 110 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- October 2023
- 146 Pages
Global
From €3353EUR$3,528USD£2,817GBP
€3945EUR$4,150USD£3,314GBP
- Report
- July 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- December 2022
- 114 Pages
Global
€7130EUR$7,500USD£5,990GBP
- Report
- November 2021
- 527 Pages
Global
From €3803EUR$4,000USD£3,195GBP
- Report
- November 2021
- 802 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- November 2021
- 1184 Pages
Global
From €5704EUR$6,000USD£4,792GBP
- Book
- May 2024
- 464 Pages
- Book
- December 2020
- 432 Pages
- Book
- February 2010
- 314 Pages

The Transfection market is a subset of the Genomics industry that focuses on the delivery of genetic material into cells. Transfection is a process that enables researchers to study gene function, gene expression, and gene regulation. It is used in a variety of applications, including gene therapy, drug discovery, and gene editing. Transfection reagents, such as plasmids, viral vectors, and liposomes, are used to deliver genetic material into cells. Transfection reagents are also used to study gene expression, gene regulation, and gene function.
The Transfection market is highly competitive, with a number of companies offering a variety of products and services. Some of the major players in the market include Thermo Fisher Scientific, Merck KGaA, Promega Corporation, Lonza Group, and Agilent Technologies. Show Less Read more